Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The biopharmaceutical company Inventiva announced that its CEO, Andrew Obenshain, will speak at the 44th annual J.P. Morgan Healthcare Conference, whi…
The biotechnology value ended the Tuesday, December 9 session at 3.64 euros, up 4% from the previous closing price of 3.50 euros. This rebound occurre…
French biotech Inventiva ended the Wednesday morning session on December 3 with a sharp decline to 3.45 euros, down 5.87% from the previous day's clos…
The stock of the French biotech company Inventiva is down by 4% this Friday at midday, standing at 3.60 euros. This decline follows the announcement o…
The biopharmaceutical company Inventiva has disclosed the voting results of its Mixed General Meeting held on November 27, 2025, according to its pres…
The stock of the Dijon-based biotech company climbs significantly this morning on Euronext Paris, continuing a positive trend that started several day…
On Tuesday, November 25, Dijon-based biotech company Inventiva recorded a 4% increase by midday, bringing the share price to 3.64 euros. This rise fol…
Inventiva has announced the conclusion of stabilization operations related to its public offering in the United States, involving American Depositary …
Inventiva has announced its cash position and revenue for the first nine months of 2025, according to a company statement.
Inventiva, a biopharmaceutical company, saw its shares close down 4.02% on Friday, November 21, at 3.465 euros, erasing some of the week's gains. This…
